APIM Therapeutics' Seed VC Round

APIM Therapeutics raised a round of funding on March 21, 2011. Investors include Sarsia Seed.

APIM Therapeutics is a biotechnology company dedicated to the development of anti-cancer agents targeting DNA repair and cell cycle control. APIM Therapeutics's pipeline of compounds includes a series…

Articles about APIM Therapeutics' Seed VC Round: